

Cefuroxime (500mg) + Clavulanic Acid (125mg)
10 tablets in 1 strip
Cash on delivery available
Cefakind-CV 500 Tablet is a combination medication containing Cefuroxime and Clavulanic acid. It belongs to the cephalosporin class of antibiotics and is prescribed to treat bacterial infections. This combination medication is formulated to enhance the antibacterial activity of Cefuroxime by inhibiting bacterial beta-lactamase enzymes, which are responsible for conferring resistance to many antibiotics.
Cefakind-CV 500 Tablet is indicated for the treatment of various bacterial infections affecting different body systems. It is commonly prescribed for respiratory tract infections such as bronchitis, sinusitis, and pneumonia, as well as urinary tract infections, skin and soft tissue infections, and certain sexually transmitted diseases. The combined action of Cefuroxime and Clavulanic acid in Cefakind-CV 500 Tablet ensures efficacy against a wide range of bacterial pathogens.
The primary benefit of Cefakind-CV 500 Tablet lies in its ability to effectively eradicate bacterial infections, thereby alleviating symptoms and promoting recovery. By inhibiting bacterial beta-lactamase enzymes, Clavulanic acid enhances the activity of Cefuroxime, making it more potent against beta-lactamase-producing bacteria. This synergistic effect ensures a higher success rate in treating infections caused by resistant bacterial strains.
Moreover, Cefakind-CV 500 Tablet offers the advantage of convenience, as it combines two active ingredients in a single tablet formulation. This simplifies dosing and enhances patient compliance, leading to better treatment outcomes.
While Cefakind-CV 500 Tablet is generally well-tolerated, it may cause certain side effects in some individuals. Common side effects associated with its use include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. Headache, dizziness, and allergic reactions such as rash, itching, or swelling of the face or throat may also occur. In rare cases, severe adverse effects such as severe diarrhea (including Clostridium difficile-associated diarrhea), liver dysfunction, or hematological abnormalities may occur. It is important to promptly report any adverse reactions to healthcare providers for evaluation and management.
Cefakind-CV 500 Tablet should be administered exactly as prescribed by healthcare providers. The recommended dosage and duration of treatment may vary depending on the type and severity of the infection, as well as individual patient factors. It is typically taken orally with a full glass of water, with or without food, as directed by the healthcare provider. Patients should adhere to the prescribed dosing regimen and complete the full course of treatment, even if symptoms improve before the medication is finished, to ensure complete eradication of the infection.
Cefakind-CV 500 Tablet exerts its antibacterial effects by interfering with the synthesis of bacterial cell walls, ultimately leading to cell death. Cefuroxime, the cephalosporin component of the medication, inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs) on the bacterial cell wall. Clavulanic acid, on the other hand, acts as a beta-lactamase inhibitor, preventing the degradation of Cefuroxime by bacterial beta-lactamase enzymes. This dual mechanism of action enhances the efficacy of Cefakind-CV 500 Tablet against a broad spectrum of bacteria, including those resistant to beta-lactam antibiotics alone.
In conclusion, Cefakind-CV 500 Tablet is a valuable therapeutic option for the treatment of bacterial infections. Its dual-action formulation ensures enhanced efficacy against resistant bacterial strains, while its convenient dosage regimen enhances patient compliance. However, vigilance for potential side effects and adherence to prescribed dosing regimens are essential to ensure optimal therapeutic outcomes and minimize the development of antibiotic resistance.
Cash on delivery available